SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2017 / Cilt: 23 - Sayı: 2

Assesment of Endometrial Vascularization with Immunohistochemical CD34 Assay in Recurrent Pregnancy Loss: A Case Control Study

Emine AYDIN
A. Taner USTA
Pages
70–73
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, we find a weak relationship between endometrial vascularization and recurrent pregnancy loss.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: We compared the endometrial vascularization in hysteroscopic endometrial samplings between recurrent pregnancy loss (RPL) and control group.
📊
Key Findings & Data:CD34 transmembrane protein was used for evaluating endometrial vascularization.
💡
Conclusion & Impact:However, we find a weak relationship between endometrial vascularization and recurrent pregnancy loss.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: We compared the endometrial vascularization in hysteroscopic endometrial samplings between recurrent pregnancy loss (RPL) and control group. STUDY DESIGN: We prospectively evaluated hysteroscopic endometrial samplings from recurrent pregnancy loss and control groups. CD34 transmembrane protein was used for evaluating endometrial vascularization. The vascularization was assessed based on thickness of vessels, diameter of the largest vessel, and number of vessels per mm2 in CD34-stained slides. RESULTS: There was no significant difference in demographic findings and vascularization, such as largest vessel diameter (p: 0.572), and number of vessels per mm2 (p: 0.982) between the two groups. CONCLUSION: The cycling endometrium is a highly angiogenic tissue and may play a role in the etiol-ogy of RPL. However, we find a weak relationship between endometrial vascularization and recurrent pregnancy loss.

🔖

Cite This Article

AYDIN, E., USTA, A. T. (2017). Assesment of Endometrial Vascularization with Immunohistochemical CD34 Assay in Recurrent Pregnancy Loss: A Case Control Study. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 23 - Sayı: 2, 70–73. https://ajindex.com/articles/177748

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319(4):189-94
  2. Chen L, Quan S, Ou XH, Kong L. Decreased endometrial vascularity in patients with antiphospholipid antibodies-associated recurrent miscarriage during midluteal phase. Fertil Steril 2012;98(6):1495-502 e1
  3. Chen L, Quan S, Li H, Chen C, Xing F, Yu Y. A compari-son of endometrial and subendometrial vascularity as-sessed by three-dimensional ultrasonography and power Doppler angiography between healthy fertile women and women with unexplained primary recurrent miscarriage. Fertil Steril 2011;95(3):1127-9
  4. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009;2(2):76-83
  5. Thorin E, Shatos MA, Shreeve SM, Walters CL, Bevan JA. Human vascular endothelium heterogeneity. A com-parative study of cerebral and peripheral cultured vascular endothelial cells. Stroke 1997;28(2):375-81
  6. Sutherland DR, Keating A. The CD34 antigen: structure, biology, and potential clinical applications. J Hematother 1992;1(2):115-29
  7. Lash GE, Innes BA, Drury JA, Robson SC, Quenby S, Bulmer JN. Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage. Hum Reprod 2012;27(1):183-95
  8. Plaisier M, Dennert I, Rost E, Koolwijk P, van Hinsbergh VW, Helmerhorst FM. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. Hum Reprod 2009; 24(1):185-97
  9. Su MT, Lin SH, Lee IW, Chen YC, Kuo PL. Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recur-rent pregnancy loss. Hum Reprod 2011;26(4):758-64
  10. Fuhrer D, Mann K, Feldkamp J, Krude H, Spitzweg C, Kratzsch J, et al. Thyroid dysfunction in pregnancy. Dtsch Med Wochenschr 2014;139(42):2148-52
  11. Rote NS. Antiphospholipid antibodies other than lupus an-ticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospho-lipid syndrome. Obstet Gynecol 1997;90(4 Pt 1):642-4. 3. de Jong PG, Goddijn M, Middeldorp S. Testing for inher-ited thrombophilia in recurrent miscarriage. Semin Reprod Med 2011;29(6):540-7
  12. Jeve YB, Davies W. Evidence-based management of re-current miscarriages. J Hum Reprod Sci 2014;7(3):159-69
  13. Stirrat GM. Recurrent